Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial

about

Long-acting FSH versus daily FSH for women undergoing assisted reproduction Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.

P2860

Q24186504-CC6AB1A5-CD39-4A28-A58C-16B687F0F5A1 Q36234933-814AC19A-4F53-4A45-8B14-200177C2F6BD

P2860

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial

Item

http://www.wikidata.org/entity/Q36952561

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Corifollitropin alfa or rFSH t ...... c analysis of the Engage trial

@en

type

Item

label

Corifollitropin alfa or rFSH t ...... c analysis of the Engage trial

@en

prefLabel

Corifollitropin alfa or rFSH t ...... c analysis of the Engage trial

@en

P1476

Corifollitropin alfa or rFSH t ...... c analysis of the Engage trial

@en

P2093

Arthur Leader

http://www.w3.org/2001/XMLSchema#string

Han Witjes

http://www.w3.org/2001/XMLSchema#string

Keith Gordon

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?

Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.

P2888

1477-7827-11-52

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7827-11-52

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Devroey

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237198729

http://www.w3.org/2001/XMLSchema#string

P6179

1023087171

http://www.w3.org/2001/XMLSchema#string

P698

23758821

http://www.w3.org/2001/XMLSchema#string

P932

3691650

http://www.w3.org/2001/XMLSchema#string

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial

about

P2860

P2860

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932